Ronald Chen/LinkedIn
Ronald Chen: New Clinical Trials Aim to Reduce Cancer Risk Before Disease Develops
Ronald Chen, Professor and Chair, Department of Radiation Oncology at University of Kansas Medical Center, shared on LinkedIn:
“Did you know clinical trials are not just for treating cancer?
There are also clinical trials looking for the best ways to prevent cancer
Researchers conduct clinical trials across the full cancer journey – including prevention,treatmentand cancer survivorship
This means we have trials that are open for people without cancer!
These trials aim to find new ways to lower the risk of cancer and improve overall health
These studies cover many types of cancer and may focus on medications, lifestyle changes, new screening methods or closer monitoring for people at higher risk
AtThe University of Kansas Cancer Center, we have many cancer prevention trials such as:
- Studying low-dosetamoxifen and acolbifene, which may help reduce cancer risk in premenopausal women with fewer side effects than the standard dose of tamoxifen
- Exploring whether an omega-3 supplement can improve metabolic health and breast cancer risk factors
- Studying a vaccine designed to reduce the risk of colorectal cancer in individuals with Lynch Syndrome.
You can explore all of our current prevention trials and see if you qualify to participate here
Cancer outcomes are often worse when risk isn’t identified early, which is why it’s so important we conduct preventative research like this
People in rural and underserved communities face more barriers to preventive care and are often underrepresented in research
Expanding access to prevention studies is key to improving outcomes for all communities.”
You can also read:Miriam Mutebi: Why Young Women Without Risk Factors Can Still Develop Breast Cancer
- Voices
acolbifeneBreast Cancercancercancer careCancer Preventioncancer risk factorscancer survivorshipcancer treatmentcolorectal cancerLynch Syndromeomega-3OncoDailyOncologyrisk factorsRonald ChentamoxifenThe University of Kansas Cancer Center
